Volitionrx (VNRX) Current Deferred Revenue (2021 - 2025)
Volitionrx (VNRX) posted Current Deferred Revenue of $353846.0 for Q4 2025, little changed on a QoQ basis from $354000.0 in Q3 2025, and up 53.85% year-over-year from $230000.0 in Q4 2024.
Volitionrx (VNRX) Current Deferred Revenue (2021 - 2025) Analysis & Trends
Volitionrx's Current Deferred Revenue history runs 5 years deep, the most recent figure standing at $353846.0 for Q4 2025.
- Quarterly Current Deferred Revenue rose 53.85% year-over-year to $353846.0 in Q4 2025, while the trailing twelve-month figure through Dec 2025 was $353846.0 (up 53.85% YoY) and the FY2025 annual result came in at $353846.0, up 53.85% from the prior year.
- Current Deferred Revenue was $353846.0 for Q4 2025 at Volitionrx, roughly flat from $354000.0 in the prior quarter.
- Across five years, Current Deferred Revenue topped out at $10.0 million in Q1 2022 and bottomed at $12512.0 in Q4 2021.
- A 5-year average of $3.6 million and a median of $230000.0 in 2024 frame the typical range for Current Deferred Revenue.
- Annual changes were most pronounced in 2022 — Current Deferred Revenue jumped 79823.27% — and 2024, when it plunged 98.99%.
- Volitionrx's Current Deferred Revenue stood at $12512.0 in 2021, then soared by 79823.27% to $10.0 million in 2022, then plunged by 98.93% to $106600.0 in 2023, then jumped by 115.76% to $230000.0 in 2024, then surged by 53.85% to $353846.0 in 2025.
- Business Quant data shows VNRX's Current Deferred Revenue at $353846.0 in Q4 2025, $354000.0 in Q3 2025, and $122441.0 in Q2 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Abbott Laboratories | 182.39 Bn | 175.10 Bn | 6.27 Bn |
| 2 | Stryker | 128.75 Bn | 125.87 Bn | 3.81 Bn |
| 3 | Medtronic | 108.59 Bn | 99.37 Bn | 6.41 Bn |
| 4 | Boston Scientific | 68.22 Bn | 66.77 Bn | 3.61 Bn |
| 5 | Edwards Lifesciences | 47.59 Bn | 43.92 Bn | 1.29 Bn |
| 6 | Dexcom | 28.58 Bn | 27.46 Bn | 750.30 Mn |
| 7 | GE HealthCare Technologies | 28.48 Bn | 26.20 Bn | 1.98 Bn |
| 8 | Smith & Nephew | 26.96 Bn | 26.39 Bn | - |
| 9 | Koninklijke Philips | 25.47 Bn | 22.34 Bn | 2.07 Bn |
| 10 | Volitionrx | 92,985.39 | -1.02 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | 353,846.00 |
| Sep 30, 2025 | 354,000.00 |
| Jun 30, 2025 | 122,441.00 |
| Mar 31, 2025 | 230,000.00 |
| Dec 31, 2024 | 230,000.00 |
| Sep 30, 2024 | 96,225.00 |
| Jun 30, 2024 | 101,097.00 |
| Mar 31, 2024 | 145,571.00 |
| Dec 31, 2023 | 106,600.00 |
| Sep 30, 2023 | 117,115.00 |
| Jun 30, 2023 | 10.00 Mn |
| Mar 31, 2023 | 10.00 Mn |
| Dec 31, 2022 | 10.00 Mn |
| Sep 30, 2022 | 10.00 Mn |
| Jun 30, 2022 | 10.00 Mn |
| Mar 31, 2022 | 10.00 Mn |
| Dec 31, 2021 | 12,512.00 |